Evaluation of a Mobile Digital Solution for Cancer Care and Research

Not Applicable

Completed

• Conditions: Cancer; Caregivers; Quality of Life
• Interventions: Other: CancerLife

• Registration Number: NCT03094741
• Lead Sponsor: Saint John's Cancer Institute

Brief Summary

The primary purpose of this pilot study is to evaluate the feasibility and acceptability of a Mobile Digital Solution in monitoring and collecting symptom burden data. The proposed study is meant to be the preparatory work for an intervention study to test the effect of Mobile Digital Solutions on improving patient outcomes by prompting early interventions for symptom relief and support of patient and family caregiver quality of life (QOL).

Detailed Description

Demographic information and patient-reported symptoms will be collected from study participants through a mobile health application called CancerLife that they can download (FREE) from their mobile device app store (Android or iOS). Participants will be asked to broadcast their emotional and physical status through a list of symptom list within the app as well as how that symptom is impacting their quality of life and activities of daily living. This data will be collected inside the application and display in easy to understand pie charts. Participants will also have the option to broadcast their entry to their social network.

Since the objective of the current feasibility study is to evaluate the feasibility and acceptability of a Mobile Digital Solution in monitoring and collecting symptom burden and QOL data, the investigators will include a standard validated instrument (FACT-G: Functional Assessment of Cancer Therapy - General) as part of this study. Participants will be asked to complete the FACT-G after initial registration and weekly for up to 4 weeks. Participants will receive electronic mail messages with a link to CancerLife weekly as a reminder to access the website.

Study Timeline

• Study First Submitted: 2017-03-21
• Study First Submitted QC: 2017-03-23
• Study First Posted: 2017-03-29
• Study Start: 2017-04-01
• Primary Completion: 2020-09-04
• Study Completion: 2020-11-05
• Status Verified: 2021-02
• Last Update Submitted: 2021-02-08
• Last Update Posted: 2021-02-09

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

• Established diagnosis of cancer
• Karnofsky Index ≥50%
• Age > 18 years

Exclusion Criteria

• Relevant cognitive impairment
• Insufficient knowledge of English language to complete the survey

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
CancerLife Feasibility Group	CancerLife	Participants will be recruited through advertisements targeted to a specific audience using the keywords cancer and cancer survivors

Primary Outcome Measures

Name	Time	Method
Feasibility/ Participation Rate	4 weeks	number of individuals who participate in the study divided by the number of individuals who opened the link

Secondary Outcome Measures

Name	Time	Method
Rate of missing data	4 weeks	number of mission data divided by total number of items available
Open Rate	4 weeks	number of individuals who open the link divided by total number of individuals reached by the advertisement
Retention rate	4 weeks	number of mission data divided by total number of items available
Participant Satisfaction	4 weeks	describe the usability, satisfaction, and desirability of the Mobile Digital Solution using a patient experience survey at the end of the study
Refusal rate	4 weeks	number of individuals who declined to participate divided by the number of individuals who opened the link

Trial Locations

Locations (1)

John Wayne Cancer Institute at Providence Saint John's Health Center; 🇺🇸 Santa Monica, California, United States